Benign and Borderline Phyllodes: Management and Follow-Up Phyllodes Management

Anita Sharma (1), Kate Hyde (2), Douglas Ferguson (3)
(1) Royal Devon & Exeter NHS Foundation Trust, Barrack Rd, Exeter, EX2 5DW, UK, United Kingdom,
(2) Royal Devon & Exeter NHS Foundation Trust, Barrack Rd, Exeter, EX2 5DW, UK, United Kingdom,
(3) University of Exeter Medical School, College of Medicine and Health, St Luke’s Campus, Exeter, EX1 2LU, UK, United Kingdom

Abstract

Background: Phyllodes tumours of the breast are benign, borderline or malignant fibroepithelial lesions. They are uncommon and usually treated with surgical or radiological excision. The association with local recurrence has led to much debate over the extent of excision margins. It has traditionally followed that clinical surveillance for local recurrence is necessary following surgery. Follow-up is without any nationally agreed protocol and is therefore variable.


Methods: After exclusions, 116 cases of benign (n=81), borderline (n=30) and malignant (n=5) phyllodes tumours were identified in a single centre, between 2005 and 2018. These were analysed using a database, electronic patient records and notes-based review.


Results: Benign recurrence occurred in six patients with complete excision of benign PTs (7.4%) and one with borderline PT (3.3%). No malignant Phyllodes tumours developed following excision of benign or borderline lesions.


Conclusions: This study of 13 years experience with 111 non-malignant Phyllodes tumours provides support for no routine clinical surveillance, but it supports patient education and open access to breast clinic.

Full text article

Generated from XML file

References

Parker SJ, Harries SA. Phyllodes tumours. Postgraduate Medical Journal. 2001;77:428-435. doi: 10.1136/pmj.77.909.428.

Cowan ML, Argani P, Cimino-Mathews A. Benign and low-grade fibroepithelial neoplasms of the breast have low recurrence rate after positive surgical margins. Modern Pathology. 2016;29:259-265. doi: 10.1038/modpathol.2015.157.

Zhang Y, Kleer CG. Phyllodes Tumor of the Breast: Histopathologic Features, Differential Diagnosis, and Molecular / Genetic Updates. Arch Pathol Lab Med. 2016; 140(7):665-71. doi: 10.5858/arpa.2016-0042-RA.

Majeski J, Stroud J. Malignant Phyllodes Tumours of the Breast: A Study in Clinical Practice. Int. Surg. 2012;97:95-98. doi: 10.9738/CC79.1.

Wen B, Mousadoust D, Warburton R, Pao JS, Dingee C, Chen L, et al. Phyllodes tumours of the breast: Outcomes and recurrence after excision. Am J Surg. 2020;219(5):790-94. doi: 10.1016/j.amjsurg.2020.02.048.

Tan BY, Acs G, Apple SK, Badve S, Bleiweiss IJ, Brogi E, et al. Phyllodes tumours of the breast: a consensus review. Histopathology. 2016;68(1):5-21. doi: 10.1111/his.12876.

Shaaban M, Barthelmes L. Benign phyllodes tumours of the breast: (Over) treatment of margins – A literature review. EJSO. 2017;43(7):1186-1190. doi: 10.1016/j.ejso.2016.10.019.

Ogunbiyi S, Perry A, Jakate K, Simpson J, George R. Phyllodes tumour of the breast and margins: How much is enough? Can J Surg. 2019;62(1):E19-E21. doi: 10.1503/cjs.005718.

Alkushi A, Arabi H, Al-Riyees L, Aldakheel AM, Al Zarah R, Alhussein F, et al. Phyllodes tumor of the breast clinical experience and outcomes: A retrospective cohort tertiary hospital experience. Ann Diag Path. 2021;51 Article 151702. doi: 10.1016/j.anndiagpath.2021.151702.

Genco IS, Purohit V, Hackman K, Ferreira L, Tugertimur B, Hajiyeva S. Benign and borderline phyllodes tumors of the breast: Clinicopathologic analysis of 205 cases with emphasis on the surgical margin status and local recurrence rate. Ann Diag Path. 2021;51 Article 151708. doi: 10.1016/j.anndiagpath.2021.151708.

Amer A, Ainley P, Thompson R, Mathers H. Postoperative follow-up practice of Phyllodes tumour in the UK: Results from a national survey. The Surgeon. 2018;16(2):74-81. doi: 10.1111/tbj.12623.

Moutte A, Chopin N, Faure C, Beurrier F, Ho Quoc C, Guinaudeau F, et al. Surgical Management of Benign and Borderline Phyllodes Tumours of the Breast. The Breast Journal. 2016;22(5):547-552. doi: 10.1111/tbj.12623.

Kirshbaum MN, Dent J, Stephenson J, Topping AE, Allinson V, McCoy M, et al. Open access follow-up care for early breast cancer: a randomised controlled quality of life analysis. Eur J Cancer Care. 2017;26:e12577. doi: 10.1111/ecc.12577.

Authors

Anita Sharma
anitasharma1@nhs.net (Primary Contact)
Kate Hyde
Douglas Ferguson
Author Biography

Kate Hyde, Royal Devon & Exeter NHS Foundation Trust, Barrack Rd, Exeter, EX2 5DW, UK



1.
Sharma A, Hyde K, Ferguson D. Benign and Borderline Phyllodes: Management and Follow-Up: Phyllodes Management. Arch Breast Cancer [Internet]. 2022 Mar. 31 [cited 2024 Jul. 15];9(3):398-400. Available from: https://archbreastcancer.com/index.php/abc/article/view/523

Article Details